Skip to main content

Advertisement

SpringerLink
Log in

Correlation of Tissue Transglutaminase with Modified Marsh Grading in Celiac Disease: A Prospective Cohort Study

  • Original Article
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Objective

To find out correlation between serum anti-tissue transglutaminase immunoglobulin-A (tTGA) levels and Marsh grading on duodenal histopathology in Celiac disease (CD).

Methods

In a prospective cohort study, a total of 52 symptomatic patients between age group of 2–18 y were enroled. All enroled patients were subjected to upper GI endoscopy by an experienced endoscopist. Two biopsies each from the bulb (D1) and second part (D2) of the duodenum were taken and Marsh grading was performed by a single experienced pathologist. Serum tTGA levels were also performed to find out correlation between serum tTGA levels and Marsh grading.

Results

The mean age of the patients was 8.21 ± 3.45 y (Range: 2–16 y). Anemia was the most common non-gastrointestinal (GI) sign and was present in 73% of the cases. However the authors could not find out any significant association between Marsh grading and hemoglobin levels (r = 0.32, p > 0.05). Serum tTGA levels were found to be positively correlated with Marsh grading (Spearmen correlation coefficient ρ = 0.74, p 0.000). Significant differences were found in tTGA levels between different Marsh gradings (ANOVA test) (p 0.000). Receiver-operator curve (ROC) analysis cut-off value of serum tTGA for predicting villous atrophy was 178.8 (nine times of cut-off value) with sensitivity of 100% and specificity of 85.7%.

Conclusions

Serum tTGA levels can be used to predict villous atrophy and biopsy may be avoided in strongly suspected cases with more than 9 times of cut-offs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for celiac disease-related terms. Gut. 2013;62:43–52.

    Article  PubMed  Google Scholar 

  2. Sapone A, Bai JC, Ciacci C, et al. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med. 2012;10:13–25.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003;163:286–92.

  4. Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology. 2001;120:636–51.

    Article  CAS  PubMed  Google Scholar 

  5. Ciclitira PJ. Celiac disease: a technical review. Gastroenterology. 2001;120:1526–40.

    Article  CAS  PubMed  Google Scholar 

  6. Green PH, Cellier C. Celiac disease. N Engl J Med. 2007;357:1731–43.

    Article  CAS  PubMed  Google Scholar 

  7. Catassi C, Fasano A. Celiac disease diagnosis: simple rules are better than complicated algorithms. Am J Med. 2010;123:691–3.

    Article  PubMed  Google Scholar 

  8. Lindfors K, Koskinen O, Kaukinen K. An update on the diagnostics of celiac disease. Int Rev Immunol. 2011;30:185–96.

    Article  PubMed  Google Scholar 

  9. Mubarak A, Nikkels P, Houwen R, Ten Kate F. Reproducibility of the histological diagnosis of celiac disease. Scand J Gastroenterol. 2011;46:1065–73.

    Article  PubMed  Google Scholar 

  10. Ravelli A, Villanacci V, Monfredini C, Martinazzi S, Grassi V, Manenti S. How patchy is patchy villous atrophy? Distribution pattern of histological lesions in the duodenum of children with celiac disease. Am J Gastroenterol. 2010;105:2103–10.

    Article  PubMed  Google Scholar 

  11. Pais WP, Duerksen DR, Pettigrew NM, Bernstein CN. How many duodenal biopsy specimens are required to make a diagnosis of celiac disease? Gastrointest Endosc. 2008;67:1082–7.

    Article  PubMed  Google Scholar 

  12. Husby S, Koletzko S, Korponay-Szabó IR, et al; ESPGHAN Working Group on Coeliac Disease Diagnosis; ESPGHAN Gastroenterology Committee; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54:136–60.

  13. Hill PG, Holmes GK. Coeliac disease: a biopsy is not always necessary for diagnosis. Aliment Pharmacol Ther. 2008;27:572–7.

    Article  CAS  PubMed  Google Scholar 

  14. Dahlbom I, Korponay-Szabó IR, Kovács JB, Szalai Z, Mäki M, Hansson T. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase. J Pediatr Gastroenterol Nutr. 2010;50:140–6.

    Article  CAS  PubMed  Google Scholar 

  15. Makharia GK, Verma AK, Amarchand R, et al. Prevalence of celiac disease in the northern part of India: a community based study. J Gastroenterol Hepatol. 2011;26:894–900.

    Article  PubMed  Google Scholar 

  16. Aro P, Ronkainen J, Storskrubb T, et al. Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population: the Kalixanda study. Scand J Gastroenterol. 2004;39:1280–8.

    Article  CAS  PubMed  Google Scholar 

  17. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–81.

    Article  CAS  PubMed  Google Scholar 

  18. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11:1185–94.

    Article  CAS  PubMed  Google Scholar 

  19. Mubarak A, Wolters VM, Gmelig-Meyling FH, Ten Kate FJ, Houwen RH. Tissue transglutaminase levels above 100 U/mL and celiac disease: a prospective study. World J Gastroenterol. 2012;18:4399–403.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Fernández-Bañares F, Alsina M, Modolell I, et al. Are positive serum-IgA-tissue-transglutaminase antibodies enough to diagnose coeliac disease without a small bowel biopsy? Post-test probability of celiac disease. J Crohns Colitis. 2012;6:861–6.

    Article  PubMed  Google Scholar 

  21. Onyeador N, Jennings N, Paul SP, Ramani P, Sandhu BK. The relationship between tissue transglutaminase antibody titers and histological classification in celiac disease. Arch Dis Child. 2014;99:A34.

    Article  Google Scholar 

  22. Vivas S, Ruiz de Morales JG, Riestra S, et al. Duodenal biopsy may be avoided when high transglutaminase antibody titers are present. World J Gastroenterol. 2009;15:4775–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Barker CC, Mitton C, Jevon G, Mock T. Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations? Pediatrics. 2005;115:1341–6.

    Article  PubMed  Google Scholar 

  24. Donaldson MR, Firth SD, Wimpee H, et al. Correlation of duodenal histology with tissue transglutaminase and endomysial antibody levels in pediatric celiac disease. Clin Gastroenterol Hepatol. 2007;5:567–73.

    Article  CAS  PubMed  Google Scholar 

  25. Mubarak A, Wolters VM, Gerritsen SA, Gmelig-Meyling FH, Ten Kate FJ, Houwen RH. A biopsy is not always necessary to diagnose celiac disease. J Pediatr Gastroenterol Nutr. 2011;52:554–7.

    Article  PubMed  Google Scholar 

  26. Trovato CM, Montuori M, Anania C, et al. Are ESPGHAN “biopsy sparing” guidelines for celiac disease also suitable for asymptomatic patients? Am J Gastroenterol. 2015;110:1485–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Contributions

RJ, VP and PS: Conceptualized the study, developed search strategy; VR: Did the study, analyzed the data and wrote the manuscript; SKV: Helped in preparing the manuscript. All authors approved the final version of manuscript. RJ will act as guarantor for the paper.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Umaid Hospital for Women and Children, Dr. S.N. Medical College, Jodhpur, Rajasthan, 342003, India

    Rakesh Jora, Vikrant Raghuvanshi, Vikas Payal, Pramod Sharma & Shree Krishan Vishnoi

Authors
  1. Rakesh Jora
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vikrant Raghuvanshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vikas Payal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pramod Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shree Krishan Vishnoi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rakesh Jora.

Ethics declarations

Conflict of Interest

None.

Source of Funding

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jora, R., Raghuvanshi, V., Payal, V. et al. Correlation of Tissue Transglutaminase with Modified Marsh Grading in Celiac Disease: A Prospective Cohort Study. Indian J Pediatr 84, 515–520 (2017). https://doi.org/10.1007/s12098-017-2323-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-017-2323-3

Keywords

Search

Navigation